Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cardiomyopathies

fluorodeoxyglucose f18 has been researched along with Cardiomyopathies in 272 studies

Research

Studies (272)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (0.74)	18.7374
1990's	4 (1.47)	18.2507
2000's	35 (12.87)	29.6817
2010's	135 (49.63)	24.3611
2020's	96 (35.29)	2.80

Authors

Authors	Studies
Aaronson, K; Cascino, T; Koelling, T; Kopin, D; Murthy, VL; Patel, VN; Pieper, JA; Poitrasson-Rivière, A	1
Blankstein, R; Divakaran, S	2
Blankstein, R; Castor, T; Dittmann, H; Gatidis, S; Gawaz, M; Glatthaar, A; Gräni, C; Greulich, S; Häntschel, M; Hetzel, J; Krumm, P; la Fougère, C; Mahrholdt, H; Mezger, K; Müller, KAL; Nikolaou, K	1
Miller, EJ; Park, J; Young, BD	1
Borges-Rosa, J; Costa, G; de Almeida, J; Ferreira, MJ; Gomes, A; Gonçalves, L; Oliveira-Santos, M; Silva, R	1
Appelbaum, J; Bhan, A; Bogun, FM; Chicos, AB; Crawford, TC; Dickfeld, T; Eagle, KA; Ellenbogen, KA; Froehlich, J; Hoogendoorn, JC; Kapa, S; Kim, HM; Kron, J; Mankad, P; Marchlinski, FE; Murgatroyd, F; Muser, D; Narasimhan, C; Patton, KK; Robinson, MR; Rosenthal, DG; Roukoz, H; Sacher, F; Santangeli, P; Sauer, WH; Siontis, KC; Soejima, K; Vedantham, V; Zeppenfeld, K; Zipse, MM	1
Fujii, S; Fukuda, M; Ishiguchi, H; Kawano, R; Kobayashi, S; Nakashima, Y; Nanno, T; Okamura, T; Suga, K; Yano, M; Yano, Y; Yoshiga, Y; Yoshitomi, R	1
Lu, Y	1
Ananthasubramaniam, K; Mshelbwala, FS	1
Bengel, FM; Diekmann, J	1
Bois, JP; Chareonthaitawee, P; Elwazir, MY	1
Bravo, PE; Han, Y; Litt, H; O'Quinn, RP; Sanghavi, M; Vidula, MK	1
Ieda, M; Ishizu, T; Kawamatsu, N; Machino-Ohtsuka, T; Sato, K; Yamamoto, M	1
Eugene, T; Fellah, I; Guyomarch, B; Jamet, B; Marteau, L; Piriou, N; Probst, V; Sébille, JC; Serfaty, JM; Tessier, R; Thollet, A; Toquet, C; Trochu, JN; Vivien, M; Warin-Fresse, K	1
Higashi, H; Inoue, T; Kawaguchi, N; Kido, T; Matsuoka, M; Miyagawa, M; Miyoshi, T; Okada, T; Okayama, H; Tanabe, Y; Tashiro, R; Yamaguchi, O	1
Aldahham, H; Gupta, R; Vender, RJ	1
Aguilar-Gallardo, JS; Arreaza, J; Contreras, JP; Lasam, G; Omar, A	1
Dong, J; Du, X; Li, Q; Li, S; Liu, T; Lv, Q; Ma, C; Wang, H; Xiong, R; Yang, X	1
Gilotra, NA; Sheikh, FH	1
Kaneko, K; Nagao, M; Sakai, A; Sakai, S; Yamamoto, A	2
Campisi, R; Merani, MF; Rodríguez, MI	1
Adams, SL; Bhattaru, A; Bravo, PE; Clancy, CB; Dubroff, J; Goldberg, L; Jean, C; Marchlinski, FE; Patel, V; Patterson, K; Peyster, E; Rojulpote, C; Rossman, M; Selvaraj, S; Vidula, MK	1
Adhaduk, M; Ashwath, M; Khalid, MU; Liu, K; Mansour, S; Paudel, B	1
Aikawa, T; Ibe, T; Manabe, O; Oyama-Manabe, N	1
Brugger, M; Gaa, J; Scheidhauer, K	1
Abe, T; Bekki, M; Fukumoto, Y; Fukuoka, R; Honda, A; Igata, S; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N	1
Alpendurada, F; Azzu, A; Baksi, J; Gardezi, SKM; Hatipoglu, S; Izgi, C; Khattar, R; Kouranos, V; Mohiaddin, R; Pennell, DJ; Sharma, R; Wechalekar, K; Wells, AU	1
Park, JB; Sohn, DW	1
Akdim, F; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; van de Garde, EMW; Veltkamp, M; Vis, R	1
Aitken, M; Balter, M; Broncano, J; Chan, MV; Davidson, M; Farrell, A; Hanneman, K; Huo, YR; Iwanochko, MR; McAllister, BJ; McInnes, MDF; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Vasquez, LI	1
Fujiki, S; Inomata, T; Ishihara, S; Ishizuka, M; Kase, M; Kashimura, T; Okubo, T; Ozaki, K; Sakai, R; Takayama, T; Watanabe, M	1
Divakaran, S	1
Alshaheen, M; Beanlands, R; Birnie, D; Boczar, KE; Caires, MC; Chow, BJ; deKemp, R; Lauzier, PT; Wiefels, C	1
Griffin, JM	1
Iso-Mustajärvi, S; Sillanmäki, S	1
Cadrin-Tourigny, J; Harel, F; Lucinian, YA; Martineau, P; Pelletier-Galarneau, M; Poenaru, R; Tremblay-Gravel, M	1
Bahl, A; Kaur, M; Nahar, U; Sharma, A; Singh, H; Singhal, M	1
Divakaran, S; John, LA; Tedrow, UB	1
Birnie, DH; Culver, DA; De Bortoli, A; Kron, J; Lehtonen, J; Murgatroyd, F; Nagai, T; Nery, PB	1
Bhambhvani, P; Farag, AA; Hage, FG; Kherajani, P; Morgan, WS	1
Arment, C; Bois, J; Castrichini, M; Churchill, R; Elwazir, M; Myasoedova, E; Rosenbaum, A; Sykora, D; Young, K	1
Azimi, AR; Doosti, R; Dousti, S; Heidari, H; Kohandel, K; Rabiei, P; Shahmohammdi, A; Shahmohammdi, S; Shajari, Z	1
Beanlands, R; Birnie, D; de Kemp, R; Juneau, D; Leung, E; Martineau, P; Nery, PB; Pelletier-Galarneau, M	1
Baumwol, J; Dembo, L; Dwivedi, G; Giudicatti, L; Marangou, J; Nolan, D	1
Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J	1
Fujii, S; Ishiguchi, H; Kajii, T; Kobayashi, S; Kohno, M; Nanno, T; Okada, M; Okuda, S; Suga, K; Yano, M; Yoshitomi, R	1
Birnie, D; Kron, J; Mankad, P; Mitchell, B	1
Nagai, T; Nagoshi, T; Tanaka, TD; Yoshimura, M	1
De Vos, N; Devos, D; Goethals, I; Van Schandevyl, S; Waterschoot, R	1
Aikawa, T; Anzai, T; Furuya, S; Hirata, K; Koyanagawa, K; Manabe, O; Naya, M; Ohira, H; Otaki, Y; Oyama-Manabe, N; Tamaki, N; Tomiyama, Y; Tsujino, I	1
Chen, EH; Chrispin, J; Gilotra, NA; Griffin, JM; Kasper, EK; Okada, DR; Saad, E; Solnes, LB; Tandri, H; Wand, AL	1
Bianco, F; Bucciarelli, V; Caulo, M; Donato Aquaro, G; Gallina, S; Grigoratos, C; Mantini, C; Mastrodicasa, D; Raffaele Cotroneo, A; Ricci, F; Tana, C	1
Gupta, K; Jadhav, R; Prasad, R; Virmani, S	1
Awaya, T; Hiroe, M; Hiroi, Y; Hotta, M; Kaneko, H; Minamimoto, R; Nakajima, K; Okazaki, O; Yamashita, H	1
Gecelter, R; Nichols, K; Van Tosh, A	1
AlBassam, O; Bowers, N; Iwanochko, R; Redwood, T	1
Gormsen, LC; Hess, S; Scholtens, AM	1
Basu, S; Kalshetty, A	1
Akiyama, K; Ando, T; Azuma, A; Fukushima, Y; Iwasaki, YK; Kumita, SI; Seino, Y; Shimizu, W; Yodogawa, K	1
Emdin, M; Genovesi, D; Giorgetti, A	1
Better, N; Cheng, MJM; Sethwala, A; Sivaratnam, D	1
Berman, DS; Cadet, S; Friedman, J; Hamilton, MA; Hayes, S; Kransdorf, E; Miller, RJH; Patel, J; Pope, A; Pournazari, P; Slomka, PJ; Tamarappoo, B; Thomson, L	1
Li, W; Li, X; Mi, H; Tian, Y; Zhang, X; Zhao, M; Zhu, Z	1
Brice, AE; Hanna, C; Ostwani, W; Wymer, DC	1
Fujita, S; Fujiyoshi, H; Hoshiga, M; Inoue, M; Kanzaki, Y; Miyamura, M; Morimoto, T; Terasaki, F	1
Ishii, J; Kato, Y; Kawai, H; Matsuyama, T; Morimoto, SI; Motoyama, S; Naruse, H; Ozaki, Y; Sarai, M; Takahashi, H; Toyama, H; Watanabe, A	1
El Ghannudi, S; Imperiale, A; Martinez, M; Ohlmann, P; Poindron, V; Schindler, TH	1
Brunken, RC	1
Alqarawi, W; Beanlands, R; Birnie, D; Celiker-Guler, E; Chakrabarti, S; de Kemp, R; Healey, JS; Hruczkowski, TW; Juneau, D; Leung, E; Medor, MC; Nery, PB; Odabashian, R; Promislow, S; Quinn, FR; Spence, S; Weng, W; Wiefels, C	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Ahmed, S; Chen, ES; Constantinescu, F; Devraj, M; Garcia, C; Gilotra, NA; Griffin, JM; Kasper, EK; Mohammed, SF; Okada, DR; Pavlovic, N; Pillarisetty, A; Saad, E; Sheikh, FH; Solnes, L; Wand, AL	1
Berger, RD; Calkins, H; Chrispin, J; Derakhshan, A; Gilotra, NA; Gowani, Z; Habibi, M; Misra, S; Okada, DR; Smith, J; Tandri, H; Zimmerman, SL	1
Hanaoka, K; Ishii, K; Iwanaga, Y; Kagioka, Y; Kaida, H; Kakehi, K; Kawamura, T; Miyazaki, S; Nakazawa, G; Okune, M; Soejima, N; Yasuda, M	1
Cuspidi, C; Milojevic, B; Milojevic, IG; Saeed, S; Tadic, M	1
Dziuk, M; Marciniak-Emmons, M; Osiecki, S; Sterliński, M	1
Cuocolo, A; Imbriaco, M; Nappi, C; Ponsiglione, A	1
Appelbaum, DE; Carter, SV; Flatley, E; Kebed, KY; Lang, RM; Moss, JD; Patel, AR; Singh, A; Tung, R; Ward, RP	1
Ali, AZ; Kishore, J; Narasimhan, C; Saggu, DK; Subramanian, M; Swamy, LTN; Swapna, N; Yalagudri, S	1
Chen, BX; Gong, JN; Guo, XJ; Huo, L; Xing, HQ; Yang, MF; Yang, YH	1
Haq, A; Jain, S; Schindler, TH	1
Akdim, F; Azzahhafi, J; Bakker, ALM; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; Swaans, MJ; Veltkamp, M	1
Avery, R; Cao, J; Cooper, LT; Lomasney, JW; Narang, A; Okwuosa, IS; Passman, RS; Schwartz, YY; Vorovich, E	1
Ando, K; Fukushima, K; Hagiwara, N; Imamura, Y; Momose, M; Nagao, M; Nakao, R; Sakai, A; Sakai, S; Suzuki, A; Watanabe, E; Yamamoto, A	1
Alam, SR; Chung, MH; Gitau, S; Makhdomi, K; Nganga, E; Ombati, KO; Shah, ASV; Vinayak, S	1
Lu, Y; Macapinlac, HA; Sweiss, NJ	2
Agrawal, T; Al-Mallah, M; Alnabelsi, TS; Bhimaraj, A; Kassi, M; Khan, M; Saleh, Y; Sukkari, MH	1
Abe, T; Bekki, M; Enomoto, M; Fukumoto, Y; Honda, A; Igata, S; Kaida, H; Kakuma, T; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N	1
Abebe, AT; Agrawal, T; Ahmed, AI; Al-Mallah, MH; Aljizeeri, A; Alnabelsi, T; Han, Y; Kassi, M; Taylor, A; Tleyjeh, IM	1
Abdelshafee, M; Abouezzeddine, OF; Amin, S; Bois, JP; Chareonthaitawee, P; Christopoulos, G; Cooper, JLT; Elwazir, M; Jouni, H; Kendi, AT; Krause, ML	1
Andrikopoulou, E; Bajaj, N; Bhambhvani, P; Manapragada, PP	1
Brunken, R; Culver, D; Ibrahim, A; Marwick, TH; Negishi, K; Negishi, T; Patel, P; Popović, ZB; Sperry, BW; Tamarappoo, B	1
Abgral, R; Chang, HL; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Karakatsanis, N; Kovacic, JC; Lala, A; Mani, V; Miller, MA; Narula, J; Padilla, M; Palmisano, A; Robson, PM; Sanz, J; Trivieri, MG	1
Schindler, TH	1
Kouranos, V; Wechalekar, K	1
Beanlands, RS; Birnie, DH; Blankstein, R; Borges-Neto, S; Chareonthaitawee, P; Chen, ES; Chen, W; Cooper, LT; Di Carli, MF; Dorbala, S; Gropler, RJ; Miller, EJ; Murthy, VL; Ruddy, TD; Schindler, TH; Tung, RH; White, ES	2
Agarwal, V; Blankstein, R	1
Brunken, R; Cerqueira, MD; Culver, DA; Hachamovitch, R; Javed, O; Oldan, JD; Sperry, BW; Tamarappoo, BK	1
Hiasa, G; Hosokawa, S; Kawada, Y; Kawaguchi, N; Kawamura, G; Kazatani, Y; Kosaki, T; Matsuoka, H; Okayama, H; Shigematsu, T; Takahashi, T; Yamada, T	1
Kiko, T; Masuda, A; Nemoto, A; Oriuchi, N; Takeishi, Y; Tominaga, H; Yoshihisa, A	1
Ahonen, AA; Hippeläinen, ET; Loimaala, AJ; Schildt, JV	1
Ahmed, J; Feiglin, D; Liu, K	1
Blankstein, R; Donal, E; Dorbala, S; Gheysens, O; Gimelli, A; Glaudemans, AWJM; Hacker, M; Hyafil, F; Jaber, WA; Lancellotti, P; Miller, EJ; Plein, S; Rouzet, F; Russell, R; Schwartz, RG; Slart, RHJA	1
O'Gara, PT; Stewart, GC; Wadhera, RK	1
Beanlands, R; Birnie, D; Ohira, H	1
Chu, G; Chung, T; Hunyor, I; Kane, A; Limaye, S; Murad, A; Riminton, S; Russo, R; Sasson, SC; Williamson, J	1
Haarala, A; Kähönen, M; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H	3
Bremer, W; Lu, Y; Sweiss, NJ	1
Beanlands, RSB; Birnie, DH; de Kemp, RA; Juneau, D; Leung, E; Nery, P; Russo, J	1
Schindler, TH; Valenta, I	1
Barnes, A; Booth, HL; Elliott, PM; Garrett, E; Groves, AM; Menezes, LJ; Mohiddin, SA; Patel, RS; Pavlou, M; Porter, JC; Sekhri, N; Wicks, EC	1
Higuchi, Y; Horiuchi, T; Kimoto, Y; Maeda, T; Tanoue, R; Tokunou, T; Tomonari, K	1
Agrawal, M; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Hulten, E; Kwong, RY; Madan, R; Mullins, E; Okada, DR; Skali, H; Steigner, M; Stewart, GC; Taqueti, VR; Veillet-Chowdhury, M; Vita, T	1
Culver, DA; Miller, EJ	1
Bhambhvani, P; Hage, FG; Iskandrian, AE; Saab, R	1
Dou, KF; Fang, W; Feng, L; He, ZX; Lu, MJ; Wang, J; Wang, L; Yang, MF; Zhao, SH	1
Awaya, T; Hiroi, Y; Hotta, M; Kubota, S; Minamimoto, R	1
Aiki, T; Hasegawa, K; Kaseno, K; Tada, H	1
Fujita, SI; Hirose, Y; Ishizaka, N; Kanzaki, Y; Terasaki, F	1
Bengel, FM; Ross, TL	1
Bhambhvani, P; Farag, A; Hage, FG; Valentin, RC	1
Bekki, M; Fukumoto, Y; Sugiyama, Y; Tahara, A; Tahara, N	1
Blankstein, R; Bravo, PE; Di Carli, MF; Singh, A	1
Bokhari, S; Flaherty, KR; Flores, RJ; Jin, Z	1
Bouvry, D; Brillet, PY; Djelbani, S; Meune, C; Nunes, H; Sgard, B; Soussan, M; Valeyre, D	1
Kim, K; Kim, SJ; Pak, K	1
Aikawa, T; Anzai, T; Kamiya, K; Kato, Y; Komoriyama, H; Koyanagawa, K; Kuzume, M; Manabe, O; Nagai, T; Naya, M; Omote, K; Tamaki, N	1
Lai, JKC; Lichtenstein, M; Sivaratnam, D; Teo, E; Toh, HB	1
Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tani, R; Yamamoto, Y	1
Abdelmessih, M; Baldassarre, LA; Miller, EJ; Rosenfeld, LE; Sharp, MB; Soufer, A	1
Aikawa, T; Anzai, T; Koyanagawa, K; Kuzume, M; Manabe, O; Naya, M; Ohira, H; Tamaki, N; Tsujino, I	1
Fowler, M; Guo, HH; Iagaru, A; Mittra, E; Ning, N; Witteles, R	1
Bois, JP; Chareonthaitawee, P; Muser, D	1
Rischpler, C; Woodard, PK	1
Alavi, A; Castro, SA; Muser, D; Santangeli, P	1
Alvi, RM; Herzog, E; Miller, EJ; Pan, H; Shahab, Z; Winkler, J; Young, BD	1
Enzan, N; Nagaoka, K; Ohtani, K; Sakamoto, I; Tsutsui, H	1
Altini, C; Bauckneht, M; Borra, A; Caobelli, F; Ferrari, C; Ferro, P; Genovesi, D; Monaco, L; Popescu, CE	1
Blankstein, R; Desai, AS; Di Carli, MF; Divakaran, S; Dorbala, S; Ghoshhajra, BB; Givertz, MM; Hedgire, SS; Kwong, RY; Lakdawala, NK; Mehra, MR; Padera, RF; Skali, H; Stewart, GC; Taqueti, VR; Zhou, W	1
Kasai, T; Kiso, K; Kumita, S; Miyagawa, M; Momose, M; Naya, M; Yoshinaga, K	1
Fujita, S; Hoshiga, M; Inuyama, M; Kanzaki, Y; Maeda, D; Miyamura, M; Takashima, S; Terasaki, F	1
Adams, HS; Agarwal, S; Ha, FJ; Palmer, SC; Thillai, M; Tweed, K; Williams, L	1
Benetos, G; Benz, DC; Buechel, RR; Fuchs, TA; Gaemperli, O; Gebhard, C; Giannopoulos, AA; Gräni, C; Huang, W; Kaufmann, PA; Messerli, M; Pazhenkottil, AP; von Dahlen, AP; von Felten, E	1
Broadhurst, PA; Choo, WK; Dawson, DK; Dempsey, OJ; Denison, AR; Miller, DR	1
Dorbala, S; Schulman, AR; Skali, H	2
Buckner, JK; Curran-Everett, D; Fenster, BE; Freeman, AM; Gottschall, EB; Hamzeh, NY; Maier, LA; Sauer, WH; Weinberger, HD	1
Ito, YM; Klaipetch, A; Manabe, O; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yoshinaga, K	1
Bartenstein, P; Becker, A; Cumming, P; Hacker, M; Haug, A; Hellweger, S; Laubender, RP; Lehner, S; Slomka, PJ; Sohn, HY; Uebleis, C; Van Kriekinge, SD	1
Beanlands, RS; Birnie, DH; DaSilva, J; de Kemp, RA; Klein, R; Leung, E; Mc Ardle, BA; Nery, PB; Renaud, J; Wells, GA	1
Bendstrup, E; Christensen, NL; Gormsen, LC; Nielsen, SS; Tolbod, LP	1
Blankstein, R; Di Carli, MF; Dorbala, S; Hainer, J; Kazemian, P; Kim, CK; Kwong, RY; Murthy, VL; Naya, M; Osborne, M; Padera, R; Skali, H; Stevenson, WG; Tokuda, M; Waller, A	1
Bengel, FM; Schatka, I	1
Bokhari, S; Paz, YE	1
Bittencourt, MS; Blankstein, R; Di Carli, MF; Dorbala, S; Hainer, J; Hulten, EA; Murthy, VL; Osborne, MT; Singh, A; Skali, H; Stewart, GC; Waller, AH	1
Ishida, Y; Kiso, K; Kondoh, C; Kumita, S; Miyagawa, M; Moroi, M; Yoshinaga, K	1
Beanlands, RS; Birnie, DH; Davis, D; Gollob, MH; Green, M; Healey, JS; Leung, E; McArdle, BA; Nair, GM; Nery, PB; Ohira, H; Yang, J	1
El Fakhri, G; Nappi, C; Ouyang, J; Rakvongthai, Y; Schaefferkoetter, J	1
Magota, K; Manabe, O; Masuda, A; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yamada, A; Yoshinaga, K	1
Koh, AS; Kok, TY; Lath, N; Sim, DK; Tan, RS	1
Hiroe, M; Ito, K; Kubota, K; Minamimoto, R; Morooka, M; Okazaki, O	1
Akasaka, T; Imanishi, T; Orii, M	1
Baptista, G; Braquet, P; Ilonca, DA; Jeandel, C; Le Moing, V; Roubille, F	1
Ashikaga, T; Hirao, K; Hirasawa, K; Isobe, M; Kato, Y; Maejima, Y; Sasaoka, T; Suzuki, J; Terashima, M; Tezuka, D; Toriihara, A; Yoshikawa, S	1
Casset-Senon, D; Cosnay, P; Diot, P; Lorette, G; Philippe, L	1
Hänninen, H; Holmström, M; Kivistö, S; Pöyhönen, P	1
Kaur, D; Lalukota, K; Narasimhan, C; Panda, S; Pavri, BB; Sundar, G	1
Gonzalez, WO; Massera, D; Travin, MI	1
Higaki, J; Inoue, T; Miki, H; Miyagawa, M; Mochizuki, T; Ogimoto, A; Okayama, H; Yokoyama, R	1
Aggarwal, NR; Chareonthaitawee, P; Cooper, LT; Gersh, BJ; Snipelisky, D; Young, PM	1
Akasaka, T; Hirata, K; Ino, Y; Kubo, T; Matsuo, Y; Orii, M; Ota, S; Shiono, Y; Tanaka, A; Tanimoto, T; Yamaguchi, T; Yamano, T	1
Bateman, TM; Coggins, T; Main, ML; Saeed, IM	1
Hirata, K; Manabe, O; Masuda, A; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yamada, A; Yoshinaga, K	1
Ajijola, O; Auerbach, M; Barrio, M; Bauer, B; Bradfield, J; Chan, S; Ferris, J; Gupta, P; Lynch, JP; Schelbert, H; Schiepers, C; Shivkumar, K; Tung, R	1
Chowdhury, M; Farooqi, F; Honarbakhsh, S; Mcbeath, K	1
Blankstein, R; Kinno, M; Waller, AH	1
Kouranos, V; Sharma, R; Underwood, SR; Wechalekar, K; Wells, AU	1
Beanlands, RSB; Bernick, J; Birnie, DH; Chow, BJW; Davies, R; deKemp, RA; Dennie, C; Dick, A; Hessian, R; Klein, R; Leung, E; Liu, P; Manabe, O; Mc Ardle, B; Nery, PB; Nishimura, M; Ohira, H; Oyama-Manabe, N; Pena, E; Renaud, J; Ruddy, TD; Sato, T; Tamaki, N; Tsujino, I; Wells, GA; Yoshinaga, K	1
Airaksinen, J; Haataja, P; Kandolin, R; Kupari, M; Lehtonen, J; Marjasuo, S; Miettinen, H; Schildt, J; Simonen, P; Tuohinen, S; Vihinen, T	1
Ehara, S; Hasegawa, T; Matsumoto, K; Otsuka, K; Sakaguchi, M; Shimada, K; Yoshiyama, M	1
Hiasa, G; Kazatani, Y; Okayama, H; Takahashi, T	1
Arakawa, J; Fujikawa, A; Kastushika, S; Nagai, T	1
Hara, T; Ito, H; Kubo, H; Masuda, A; Niitsuma, T; Takeishi, Y; Takenoshita, S; Wada, K; Yamaki, T	1
Emmett, L; Hickey, AJ; Huang, Y; Le, K; Tang, R; Wang, JT; Wang, L	1
Bertic, M; Tandon, S; Wisenberg, G	1
Akabuogu, EU; Phyu, SM; Smith, TA	1
Ananthasubramaniam, K; Cabrera, R	1
Lu, Y; Miller, CT; Sweiss, NJ	1
Bois, JP; Chareonthaitawee, P	1
Higo, T; Ikeda, S; Ohtani, K; Uwatoku, T	1
Ahmadian, A; Berman, J; Govender, P; Miller, EJ; Pawar, S; Ruberg, FL	1
Birnie, DH; Kandolin, R; Kupari, M; Nery, PB	1
Bateman, TM	1
Bernt, R; Haller, J; Hergan, K; Mirzaei, S; Zandieh, S	1
Lawal, I; Sathekge, M	1
Inoko, M; Nakane, E; Nakasone, K; Sekihara, T	1
Alavi, A; Cheng, G; Lee, PI	1
Lakhter, V; Manoushagian, SJ; Patil, PV	1
Ali, Z; Aurangabadkar, HU; Bradfield, JS; Kumar, KS; Narasimhan, C; Shelke, AB	1
Grant, C; Lu, Y; Sweiss, NJ; Xie, K	1
López-Aguilera, J; López-Granados, A; Mesa-Rubio, D	1
Chen, ES; Kasper, EK; Kovell, L; Kruse, MJ; Moller, DR; Pomper, MG; Schindler, TH; Solnes, L	1
Bois, JP; Chareonthaitawee, P; Gersh, BJ	1
Hayashi, H; Katoh, H; Matoh, F; Odagiri, K; Saitoh, T; Sakahara, H; Satoh, H; Shiraki, K; Takehara, Y; Urushida, T	1
Gao, R; He, ZX; Hu, S; Liu, XJ; Sayre, JW; Schelbert, HR; Schindler, TH; Tian, Y; Wei, H; Wu, Q; Zhang, X	1
Candell-Riera, J; Esteves, FP; Faber, TL; Folks, RD; Garcia, EV; Ornelas, M; Santana, CA; Santana, LF; Sanyal, R; Soler-Peter, M; Verdes, L	1
Askew, JW; Chareonthaitawee, P; Gibbons, R; Miller, T	1
Blankstein, R; Buckley, O; Desai, A; Di Carli, M; Dorbala, S; Doyle, L; Kwong, R; Lakdawala, N; Padera, R	1
Beanlands, RS; Birnie, D; DeKemp, RA; Guo, A; Lalonde, M; Ruddy, TD; Tang, AS; Wassenar, R; Williams, K	1
Canty, JM; deKemp, RA; Fallavollita, JA; Luisi, AJ; Yun, E	1
Britton, KA; Katz, JT; Levy, BD; Loscalzo, J; Stevenson, WG	1
Balt, JC; Boom, P; Uijlings, R; Wever, E	1
Boer, C; Bosmans, JW; Diamant, M; Handoko, LM; Huisman, MC; Lammertsma, AA; Lubberink, M; Molthoff, CF; Ouwens, MD; van den Brom, CE; Vlasblom, R	1
Baba, K; Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Narula, J; Nitta, Y; Tahara, A; Tahara, N	1
Arrighi, JA; Brancato, SC	1
Graner, M; Kandolin, R; Kivistö, SM; Kupari, M; Lehtonen, J; Salmenkivi, K; Schildt, J	1
Ohira, H; Tsujino, I; Yoshinaga, K	1
Manabe, O; Nishimura, M; Ohira, H; Oyama, N; Sato, T; Tsujino, I; Yoshinaga, K	1
Brunken, R; Culver, DA; Isiguzo, M; Tchou, P; Xu, M	1
Bokhari, S; Chen, S	1
Boon, NA; Clark, JC; Dweck, MR; Fletcher, AM; Jones, C; Joshi, NV; Marsden, M; McKillop, G; Newby, DE; Pessotto, R; Richardson, H; Rudd, JH; Salter, DM; van Beek, EJ; Wallace, WA; White, A	1
Adams, WM; Bhatnagar, G; Iyengar, S; Maviki, M; Suresh, P; Vardhanabhuti, V; Venkatanarasimha, N	1
Beanlands, RS; Birnie, D; DaSilva, JN; de Kemp, RA; Gollob, MH; Guo, A; Ruddy, TD; Tang, AS; Thomson, K; Williams, K	1
Fukunaga, T; Imamura, T; Kato, J; Kawano, N; Kawano, S; Kitamura, K; Masuyama, H; Mihara, K; Shimao, Y; Toyoda, K; Ueda, A; Yoshimura, Y	1
Beanlands, RS; Birnie, D; Dasilva, J; Dekemp, RA; Gulenchyn, KY; Leung, E; Mylonas, I; Nery, P; Wells, GA; Williams, K; Wisenberg, G; Youssef, G	1
Manabe, O; Ohira, H; Oyama-Manabe, N; Tamaki, N; Tsutsui, H	1
Baba, Y; Doi, YL; Furuno, T; Kawada, Y; Kitaoka, H; Kubo, T; Matsumura, Y; Okawa, M; Sugiura, T; Yamanaka, S; Yamasaki, N	1
Brown, RK; Corbett, JR; Dvorak, RA; Kazerooni, EA; Lobert, P; Wong, KK	1
Dahlbom, M; Huang, SC; Prior, JO; Sayre, J; Schelbert, HR; Schindler, TH; Zhang, X	1
Beanlands, RS; Birnie, D; Cocker, MS; DaSilva, J; deKemp, RA; Leung, E; Mc Ardle, BA; Nery, PB; Ohira, H	1
Hiroe, M; Ito, K; Kubota, K; Minaminoto, R; Morooka, M; Okazaki, O	1
Akioka, K; Shirai, N; Takagi, M; Takeuchi, K; Yamagishi, H; Yoshikawa, J; Yoshiyama, M	1
Bax, JJ; Biagini, E; Bountioukos, M; Elhendy, A; Kertai, MD; Krenning, B; Krenning, EP; Poldermans, D; Rizzello, V; Roelandt, JR; Schinkel, AF; Valkema, R; Vourvouri, EC	1
Hardoff, R; Maisey, MN; Steinmetz, AP	1
Morita, H; Nagai, R; Uno, K; Yamada, N; Yokoyama, I	1
Fujita, T; Horita, Y; Kaku, B; Kanaya, H; Ohka, T; Uno, Y; Yamazaki, T	1
Bekkers, SC; Gorgels, AP; Smedema, JP; Snoep, G; van Kroonenburgh, MJ	1
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; van der Wall, EE	1
Ikeda, D; Ishimaru, S; Ito, N; Kamigaki, M; Nishimura, M; Ohira, H; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E	1
Bax, JJ; Biagini, E; Poldermans, D; Rambaldi, R; Rizzello, V; Roelandt, JR; Valkema, R	1
Iwado, Y; Kohno, M; Ohmori, K; Senda, S; Shinomiya, K	1
Arai, M; Endo, M; Goto, K; Hasegawa, A; Kaneko, Y; Kurabayashi, M; Morita, M; Nakano, A; Okamoto, E; Sasamoto, T; Suguta, M; Umezawa, K	1
Ichinose, A; Jingu, K; Kaneta, T; Nemoto, K; Ogawa, Y; Takai, Y; Yamada, S	1
Ishimaru, S; Nishimura, M; Oyama, N; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E	1
Beek, A; Hanrath, P; Kühl, HP; van der Weerdt, A; van Rossum, A; Visser, F	1
Inoue, N; Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsumoto, K; Matsushita, K; Sumita, S; Takahashi, N; Uchino, K; Umemura, S	1
Geukens, R; Reenaers, V; Smedema, JP	1
Azuma, A; Hashimoto, T; Irie, H; Ito, K; Kinoshita, N; Koide, M; Matsubara, H; Nakamura, R; Sawada, T; Tamaki, S; Taniguchi, T; Yokoi, H	1
Hosokawa, R; Kanao, S; Kimura, T; Kita, T; Kubo, S; Tadamura, E; Togashi, K; Yamamuro, M	1
Altenberger, J; Pirich, C; Rendl, G	1
Comans, EF; de Cock, CC; Knaapen, P; Lammertsma, AA; van Campen, CM; van der Weerdt, AP; Visser, CA; Visser, FC	1
Brunken, RC; Culver, DA; Pandya, C; Schoenhagen, P; Tchou, P	1
Ceriani, L; Gallino, A; Györik, S; Menafoglio, A; Wyttenbach, R	1
Hibino, T; Hiramitsu, S; Ichiro Morimoto, S; Kako, N; Kato, K; Kato, Y; Kuroda, M; Mizoguchi, Y; Morikawa, M; Oguri, M; Yajima, K; Yokoi, K	1
Ishimaru, S; Miura, M; Nishimura, M; Ohira, H; Oyama, N; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E	1
Chida, K; Inui, N; Miwa, S; Miyazaki, H; Suda, T; Torizuka, T	1
Mazziotta, JC; Phelps, ME; Schelbert, HR	1
Ashmarin, IIu	1
Schwaiger, M; von Schulthess, GK	1
Cleophas, AJ; Cramer, MJ; Kuijper, AF; Meeder, JG; Niemeyer, MG; van der Wall, EE	1
Aoyagi, K; Endo, K; Hatori, T; Inoue, T; Iwasaki, T; Matsubara, K; Miyajima, A; Nagai, R; Okumura, W; Otake, H; Sato, H; Seki, R; Suzuki, T; Toyama, T; Ueda, T	1
Fujii, K; Fujiwara, M; Hasegawa, R; Himi, T; Kuroda, T; Kuwabara, Y; Masuda, Y; Matsuno, K; Mikami, Y; Nakaya, J; Watanabe, S	1
Ishida, Y; Nakatani, S; Tachibana, T	1
Cook, GJ	1
Bøttcher, M; Flø, C; Kaltoft, A; Nielsen, TT; Rehling, M; Sand, NP	1
Fritsch, P; Kowald, E; Moncayo, R; Pachinger, O; Riccabona, G; Schauer, N; Schmuth, M; Sepp, N	1
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; Vourvouri, EC	1

Reviews

49 review(s) available for fluorodeoxyglucose f18 and Cardiomyopathies

Article	Year
Potential novel imaging targets of inflammation in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis	2022
[Clinical use of Cardiac Nuclear Medicine in Germany]. Deutsche medizinische Wochenschrift (1946), 2022, Volume: 147, Issue:9 Topics: Amyloidosis; Cardiomyopathies; Fluorodeoxyglucose F18; Germany; Glucose; Humans; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Tomography, Emission-Computed, Single-Photon	2022
Utilization of cardiac imaging in sarcoidosis. Expert review of cardiovascular therapy, 2022, Volume: 20, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis	2022
The role of PET in the management of sarcoidosis. Current opinion in pulmonary medicine, 2022, 09-01, Volume: 28, Issue:5 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prospective Studies; Sarcoidosis	2022
Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT. Current cardiology reports, 2022, Volume: 24, Issue:12 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon	2022
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:4 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity	2023
Cardiac sarcoidosis. Heart (British Cardiac Society), 2023, 07-12, Volume: 109, Issue:15 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Positron-Emission Tomography; Sarcoidosis	2023
Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology, 2023, Volume: 307, Issue:2 Topics: Adult; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Prognosis; Sarcoidosis	2023
Radionuclide Assessment of Sarcoidosis. Cardiology clinics, 2023, Volume: 41, Issue:2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sarcoidosis	2023
Cardiac Sarcoidosis. Current cardiology reports, 2019, 11-25, Volume: 21, Issue:12 Topics: Canada; Cardiomyopathies; Contrast Media; Death, Sudden, Cardiac; Defibrillators, Implantable; Fluorodeoxyglucose F18; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sarcoidosis; Treatment Outcome	2019
The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis. Current medical imaging reviews, 2019, Volume: 15, Issue:1 Topics: Cardiac Imaging Techniques; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2019
Cardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Myocardium; Myxoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2020
Patient Preparation and Patient-related Challenges with FDG-PET/CT in Infectious and Inflammatory Disease. PET clinics, 2020, Volume: 15, Issue:2 Topics: Anticoagulants; Blood Glucose; Cardiomyopathies; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Infections; Inflammation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urologic Diseases	2020
PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises. PET clinics, 2020, Volume: 15, Issue:2 Topics: Arteritis; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, Systemic; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Thoracic Diseases	2020
The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis. Current radiopharmaceuticals, 2021, Volume: 14, Issue:3 Topics: Cardiomyopathies; Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Myocarditis; Pericarditis; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sarcoidosis	2021
Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential Journal of nuclear medicine technology, 2020, Volume: 48, Issue:4 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Time Factors	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis. Heart failure reviews, 2021, Volume: 26, Issue:3 Topics: Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis	2021
Diagnosis of cardiac sarcoidosis: a primer for non-imagers. Heart failure reviews, 2022, Volume: 27, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Sarcoidosis	2022
The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sarcoidosis	2021
PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection). Radiologic clinics of North America, 2021, Volume: 59, Issue:5 Topics: Cardiomyopathies; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2021
Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by Journal of medical case reports, 2017, Oct-20, Volume: 11, Issue:1 Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2017
Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:1 Topics: Cardiology; Cardiomyopathies; Disease Progression; Fibrosis; Fluorodeoxyglucose F18; Heart Failure; Humans; Inflammation; Myocardium; Regeneration	2019
Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:1 Topics: Algorithms; Cardiology; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Inflammation; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Sarcoidosis	2019
Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sarcoidosis; Sensitivity and Specificity	2020
PET/CT Evaluation of Cardiac Sarcoidosis. PET clinics, 2019, Volume: 14, Issue:2 Topics: Biomedical Technology; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2019
PET/MR Imaging in Cardiovascular Imaging. PET clinics, 2019, Volume: 14, Issue:2 Topics: Cardiomyopathies; Cardiovascular Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Multimodal Imaging; Myocardial Perfusion Imaging; Myocarditis; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2019
Potential Role of PET in Assessing Ventricular Arrhythmias. PET clinics, 2019, Volume: 14, Issue:2 Topics: Arrhythmias, Cardiac; Cardiomyopathies; Chagas Cardiomyopathy; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis	2019
The role of positron emission tomography in the assessment of cardiac sarcoidosis. The British journal of radiology, 2019, Volume: 92, Issue:1100 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2019
Recommendations for Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Japan; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Sarcoidosis	2019
Imaging in Suspected Cardiac Sarcoidosis: A Diagnostic Challenge. Current cardiology reviews, 2020, Volume: 16, Issue:2 Topics: Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Sarcoidosis	2020
(18)F-FDG PET/CT for the assessment of myocardial sarcoidosis. Current cardiology reports, 2013, Volume: 15, Issue:5 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome	2013
18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Current cardiology reports, 2013, Volume: 15, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2013
Advanced imaging of cardiac sarcoidosis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:1 Topics: Cardiomyopathies; Clinical Trials as Topic; Fluorodeoxyglucose F18; Heart Diseases; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis	2014
The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy. The international journal of cardiovascular imaging, 2014, Volume: 30, Issue:2 Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathies; Echocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sarcoidosis; Tomography, X-Ray Computed	2014
Assessment of cardiac sarcoidosis with advanced imaging modalities. BioMed research international, 2014, Volume: 2014 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging, Cine; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2014
Advances in imaging for diagnosis and management of cardiac sarcoidosis. European heart journal. Cardiovascular Imaging, 2015, Volume: 16, Issue:9 Topics: Cardiac Imaging Techniques; Cardiomyopathies; Cause of Death; Disease-Free Survival; Early Diagnosis; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Image Interpretation, Computer-Assisted; Immunosuppressive Agents; Magnetic Resonance Imaging, Cine; Male; Mass Screening; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Risk Assessment; Sarcoidosis; Severity of Illness Index; Survival Analysis	2015
Advances in radionuclide imaging of cardiac sarcoidosis. British medical bulletin, 2015, Volume: 115, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Sarcoidosis; Tomography, Emission-Computed, Single-Photon	2015
Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis. Clinical nuclear medicine, 2016, Volume: 41, Issue:7 Topics: Anticoagulants; Cardiomyopathies; Fluorodeoxyglucose F18; Heparin; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Regression Analysis; ROC Curve; Sarcoidosis; Sensitivity and Specificity	2016
F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. British medical bulletin, 2016, Volume: 120, Issue:1 Topics: Cardiomyopathies; Endocarditis; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Pericarditis; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals	2016
¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:9 Topics: Adrenal Cortex Hormones; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Sarcoidosis	2011
Extra-pulmonary manifestations of sarcoidosis. Clinical radiology, 2012, Volume: 67, Issue:3 Topics: Cardiomyopathies; Central Nervous System Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urologic Diseases	2012
The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:2 Topics: Canada; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; ROC Curve; Sarcoidosis	2012
Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT. Clinical radiology, 2013, Volume: 68, Issue:1 Topics: Adipose Tissue, Brown; Artifacts; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Atria; Heart Diseases; Heart Ventricles; Humans; Leukemia; Lymphoma; Multimodal Imaging; Myocardium; Organ Specificity; Papillary Muscles; Pericarditis; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2013
The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:2 Topics: Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis	2013
Positron computed tomography for studies of myocardial and cerebral function. Annals of internal medicine, 1983, Volume: 98, Issue:3 Topics: Alzheimer Disease; Animals; Brain; Brain Neoplasms; Cardiomyopathies; Cerebrovascular Disorders; Deoxyglucose; Dogs; Epilepsy; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Huntington Disease; Regional Blood Flow; Tomography, Emission-Computed	1983
[Positron emission tomography: the prospects for studying myocardial metabolism in vivo]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1984, Volume: 7, Issue:2 Topics: Carbon Radioisotopes; Cardiomyopathies; Deoxyglucose; Fatty Acids, Nonesterified; Fluorine; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Myocardium; Nitrogen Radioisotopes; Oxygen Radioisotopes; Prognosis; Radioisotopes; Tomography, Emission-Computed	1984
[Clinical indications for PET of the heart]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1993, Aug-24, Volume: 82, Issue:34 Topics: Acetates; Cardiomyopathies; Coronary Disease; Deoxyglucose; Fatty Acids; Fluorodeoxyglucose F18; Humans; Myocardial Infarction; Myocardium; Tomography, Emission-Computed	1993
Comparison of thallium scintigraphy and positron emission tomography. Angiology, 1997, Volume: 48, Issue:10 Topics: Ammonia; Cardiomyopathies; Coronary Circulation; Coronary Disease; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Glucose; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nitrogen Radioisotopes; Prognosis; Radiopharmaceuticals; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed; Ventricular Function, Left	1997

Trials

11 trial(s) available for fluorodeoxyglucose f18 and Cardiomyopathies

Article	Year
Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes. Journal of the American Heart Association, 2020, Volume: 9, Issue:17 Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathies; Case-Control Studies; Cohort Studies; Cost of Illness; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Immunosuppression Therapy; Incidence; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Tachycardia, Ventricular	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study). BMC cardiovascular disorders, 2021, 05-08, Volume: 21, Issue:1 Topics: Cardiomyopathies; Computed Tomography Angiography; Coronary Disease; COVID-19; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals	2021
What Is the Optimal Method on Myocardial Suppression in FDG PET/CT Evaluation of Cardiac Sarcoidosis? Clinical nuclear medicine, 2021, Nov-01, Volume: 46, Issue:11 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2021
How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body International journal of cardiology, 2018, 02-15, Volume: 253 Topics: Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Sarcoidosis; Whole Body Imaging	2018
Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:6 Topics: Adult; Aged; Cardiomyopathies; Cross-Over Studies; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Heparin; Humans; Insulin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Somatostatin	2013
Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis. Annals of nuclear medicine, 2014, Volume: 28, Issue:7 Topics: Biological Transport; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed; Ultrasonography	2014
The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:2 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome	2017
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation, 2012, Jan-03, Volume: 125, Issue:1 Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed	2012
[Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis]. Kaku igaku. The Japanese journal of nuclear medicine, 1999, Volume: 36, Issue:4 Topics: Adult; Aged; Cardiomyopathies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1999
Functional evaluation of myocardial viability by 99mTc tetrofosmin gated SPECT--a quantitative comparison with 18F fluorodeoxyglucose positron emission CT (18F FDG PET). Annals of nuclear medicine, 1999, Volume: 13, Issue:3 Topics: Adult; Aged; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1999

Other Studies

213 other study(ies) available for fluorodeoxyglucose f18 and Cardiomyopathies

Article	Year
The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2022
FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis	2022
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:3 Topics: Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2022
[ International journal of cardiology, 2022, Jan-15, Volume: 347 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2022
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis. JAMA cardiology, 2022, 02-01, Volume: 7, Issue:2 Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Inflammation; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome	2022
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis. Heart (British Cardiac Society), 2022, Volume: 108, Issue:6 Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cardiomyopathies; Death, Sudden, Cardiac; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Myocarditis; Oxidative Stress; Prospective Studies; Risk Factors; Sarcoidosis; Tachycardia, Ventricular	2022
Extensive Biventricular Cardiac Sarcoidosis Detected on FDG PET/CT Using a 72-Hour Ketogenic Diet Preparation Protocol. Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8 Topics: Cardiomyopathies; Contrast Media; Diet, Ketogenic; Fluorodeoxyglucose F18; Gadolinium; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis	2022
All that glitters is not sarcoidosis: Importance of systematic review of Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:3 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
Not All That Glitters Is Sarcoidosis: Septal Perforator Myocardial Infarction Mimicking Isolated Cardiac Sarcoidosis. Circulation. Cardiovascular imaging, 2022, Volume: 15, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2022
Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis. Journal of the American Heart Association, 2022, 07-05, Volume: 11, Issue:13 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Japan; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2022
18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy. Circulation. Cardiovascular imaging, 2022, Volume: 15, Issue:7 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2023
Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report. Medicine, 2022, Aug-26, Volume: 101, Issue:34 Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocarditis; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2022
Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias. ESC heart failure, 2022, Volume: 9, Issue:6 Topics: Adalimumab; Arrhythmias, Cardiac; Atrioventricular Block; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Middle Aged; Mycophenolic Acid; Myocarditis; Positron Emission Tomography Computed Tomography; Sarcoidosis	2022
Atrial Fibrillation and Cardiac Sarcoidosis: The Aperture Widens Through the Lens of FDG-PET Imaging. JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:9 Topics: Atrial Fibrillation; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis	2022
FDG uptake patterns in isolated and systemic cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:3 Topics: Cardiomyopathies; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2023
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:11 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis	2022
Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long? JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:11 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis	2022
Serial assessment of cardiac involvement in sarcoidosis by delayed Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:5 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
PET-CT in the diagnosis of cardiac and pulmonary sarcoidosis. Wiener klinische Wochenschrift, 2023, Volume: 135, Issue:7-8 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary	2023
Utility of very long fasting to detect myocardial inflammation in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:5 Topics: Cardiomyopathies; Fasting; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Sarcoidosis	2023
Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias. Heart (British Cardiac Society), 2023, 04-25, Volume: 109, Issue:10 Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Arrest; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Sarcoidosis	2023
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Methotrexate; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2023
Optimal Timing of Serial International heart journal, 2023, Mar-31, Volume: 64, Issue:2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2023
Linking cardiac and extracardiac sarcoidosis and their clinical outcome: Annals of nuclear medicine, 2023, Volume: 37, Issue:7 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
What is this image? 2023 Image 6 result: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:3 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
Sex differences in cardiac sarcoidosis. Heart (British Cardiac Society), 2023, 08-24, Volume: 109, Issue:18 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Sarcoidosis; Sex Characteristics; Tachycardia, Ventricular	2023
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6 Topics: Atrioventricular Block; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Myocardial Perfusion Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2023
Multimodality imaging of myocardial tuberculosis presenting as right ventricular cardiomyopathy: A case report. Asian cardiovascular & thoracic annals, 2023, Volume: 31, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis	2023
Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis. The American journal of cardiology, 2023, 09-15, Volume: 203 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis	2023
Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis. The American journal of cardiology, 2023, 10-15, Volume: 205 Topics: Adalimumab; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Infliximab; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Tumor Necrosis Factor-alpha	2023
Typical trident sign and cardiac involvement in a patient suspected to Sarcoidosis despite negative whole-body FDG-PET: a case report. Journal of medical case reports, 2023, Nov-30, Volume: 17, Issue:1 Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2023
Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study. JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:11 Pt 1 Topics: Cardiomyopathies; Coronary Circulation; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis	2019
The Utility of Whole Body Heart, lung & circulation, 2020, Volume: 29, Issue:1 Topics: Australia; Cardiomyopathies; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoidosis	2020
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis. Journal of the American Heart Association, 2019, 09-17, Volume: 8, Issue:18 Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug Therapy, Combination; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome	2019
Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis. Circulation journal : official journal of the Japanese Circulation Society, 2019, 11-25, Volume: 83, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome	2019
Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/ Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6 Topics: Adult; Biopsy; Cardiomyopathies; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity	2020
Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI. Journal of cardiovascular medicine (Hagerstown, Md.), 2020, Volume: 21, Issue:4 Topics: Adult; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Steroids; Treatment Outcome	2020
Prognostic Value of JACC. Cardiovascular imaging, 2020, Volume: 13, Issue:4 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2020
Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2020, Volume: 13, Issue:5 Topics: Adrenal Cortex Hormones; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis; Time Factors; Treatment Outcome	2020
Proliferation imaging with Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:2 Topics: Adult; Aged; Carbon Radioisotopes; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Thionucleosides; Thymidine	2021
Normal variant left ventricular lateral wall 18FDG uptake in cardiac sarcoid evaluations. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:1 Topics: Adult; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2021
Acute inflammatory pericarditis secondary to cardiac sarcoidosis evaluated by 18F-fluorodeoxyglucose PET/CT imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Middle Aged; Pericarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis	2021
Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis. International journal of cardiology, 2020, 08-15, Volume: 313 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2020
18F-FDG PET/CT identifying cardiac abscess formation prior to cardiac CT. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:5 Topics: Abscess; Aged; Cardiomyopathies; Endocarditis; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2022
Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value. The international journal of cardiovascular imaging, 2020, Volume: 36, Issue:10 Topics: Aged; Cardiomyopathies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left	2020
A Patient with Cardiac Sarcoidosis in Whom an Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxyglucose and Sustained Ventricular Tachycardia Recurred 3.5 Years after Discontinuing Oral Corticosteroid Therapy. Internal medicine (Tokyo, Japan), 2020, Sep-15, Volume: 59, Issue:18 Topics: Adrenal Cortex Hormones; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Sarcoidosis; Tachycardia, Ventricular	2020
Diagnosis of isolated cardiac sarcoidosis based on new guidelines. ESC heart failure, 2020, Volume: 7, Issue:5 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis	2020
68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis. Clinical nuclear medicine, 2020, Volume: 45, Issue:9 Topics: Adult; Aged; Cardiomyopathies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome	2020
Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:1 Topics: Cardiomyopathies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2022
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience. Journal of cardiac failure, 2021, Volume: 27, Issue:1 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left	2021
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis. The American journal of cardiology, 2020, 11-01, Volume: 134 Topics: Adult; Aged; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Ventricular Fibrillation	2020
Diagnostic utility of fusion Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2 Topics: Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2022
Feasibility of The international journal of cardiovascular imaging, 2021, Volume: 37, Issue:3 Topics: Adolescent; Adult; Aged; Cardiomyopathies; Endocarditis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Whole Body Imaging; Young Adult	2021
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2022
Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study. The international journal of cardiovascular imaging, 2021, Volume: 37, Issue:4 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular	2021
Pre-Treatment Myocardial JACC. Cardiovascular imaging, 2021, Volume: 14, Issue:10 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2021
Comparison of Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5 Topics: Cardiomyopathies; Fibrosis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypertension, Pulmonary; Magnetic Resonance Spectroscopy; Positron Emission Tomography Computed Tomography	2022
Added value gated PET with phase analysis for the detection of scar burden and prognostication in cardiac sarcoidosis? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:3 Topics: Cardiomyopathies; Cicatrix; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis	2022
Effectiveness and safety of infliximab in cardiac Sarcoidosis. International journal of cardiology, 2021, 05-01, Volume: 330 Topics: Cardiomyopathies; Cohort Studies; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoidosis; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2021
A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis? Circulation. Heart failure, 2021, Volume: 14, Issue:3 Topics: Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Disease Progression; Echocardiography; Fluorodeoxyglucose F18; Giant Cells; Granuloma; Heart Block; Heart Failure; Heart Transplantation; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Troponin I	2021
Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:3 Topics: Adult; Aged; Cardiomyopathies; Fatty Acids; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Iodobenzenes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Tomography, Emission-Computed, Single-Photon	2021
Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5 Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed	2022
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. Journal of cardiac failure, 2022, Volume: 28, Issue:2 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2022
Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis. The American journal of cardiology, 2017, 05-15, Volume: 119, Issue:10 Topics: Adult; Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Ventricular Function, Left	2017
Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2018, Volume: 11, Issue:1 Topics: Adult; Aged; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Severity of Illness Index	2018
Emergence of Integrated Cardiac Magnetic Resonance/Positron Emission Tomography Imaging as the Preferred Imaging Modality in Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2018, Volume: 11, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Sarcoidosis	2018
Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:2 Topics: Atrioventricular Block; Cardiomyopathies; Female; Finland; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prevalence; Sarcoidosis	2019
Joint SNMMI-ASNC Expert Consensus Document on the Role of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:8 Topics: Cardiomyopathies; Consensus; Documentation; Expert Testimony; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Sarcoidosis; Societies, Medical; Treatment Outcome	2017
Joint SNMMI-ASNC expert consensus document on the role of Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:5 Topics: Cardiomyopathies; Consensus; Defibrillators, Implantable; Fluorodeoxyglucose F18; Humans; Pacemaker, Artificial; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis	2017
Maximizing the Prognostic Value of Cardiac PET in Patients With Suspected Cardiac Sarcoidosis: A Simple Semiquantitative Score May Help. JACC. Cardiovascular imaging, 2018, Volume: 11, Issue:2 Pt 2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Sarcoidosis	2018
Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on JACC. Cardiovascular imaging, 2018, Volume: 11, Issue:2 Pt 2 Topics: Adult; Aged; Cardiomyopathies; Coronary Circulation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Severity of Illness Index; Time Factors	2018
Radiation-Induced Cardiomyopathy Incidentally Detected on Oncology Circulation journal : official journal of the Japanese Circulation Society, 2018, 03-23, Volume: 82, Issue:4 Topics: Cardiomyopathies; Deglutition Disorders; Echocardiography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiotherapy	2018
Cardiac sarcoidosis after glucocorticoid therapy evaluated by Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:2 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis	2018
Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients. European heart journal. Cardiovascular Imaging, 2018, 03-01, Volume: 19, Issue:3 Topics: Analysis of Variance; Cardiomyopathies; Cohort Studies; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, University; Humans; Lymph Nodes; Male; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Reference Values; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index	2018
A 54-year-old man with new-onset ventricular fibrillation. Heart (British Cardiac Society), 2017, Volume: 103, Issue:23 Topics: Biopsy; Cardiomyopathies; Cardiopulmonary Resuscitation; Defibrillators; Electric Countershock; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Ventricular Fibrillation	2017
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:1 Topics: Biopsy; Cardiology; Cardiomyopathies; Diagnostic Imaging; Echocardiography; Europe; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Reproducibility of Results; Sarcoidosis; Societies, Medical; Tomography, X-Ray Computed; United States	2018
A 52-Year-Old Man With Unheralded Syncope. JAMA cardiology, 2017, Dec-01, Volume: 2, Issue:12 Topics: Atrioventricular Block; Bradycardia; Bundle-Branch Block; Cardiomyopathies; Echocardiography; Electrocardiography; Exercise Test; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Syncope; Tomography, Emission-Computed, Single-Photon	2017
Reply: Using and Interpreting Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:12 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis	2017
Novel ECG parameters are strongly associated with inflammatory International journal of cardiology, 2017, Dec-15, Volume: 249 Topics: Adult; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sarcoidosis	2017
Serial FDG-PET/CT Imaging in the Management of Cardiac Sarcoidosis. Clinical nuclear medicine, 2018, Volume: 43, Issue:2 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis; Time Factors	2018
Isolated cardiac sarcoidosis - A rare disease entity? International journal of cardiology, 2018, 02-15, Volume: 253 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Sarcoidosis	2018
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. European heart journal. Cardiovascular Imaging, 2018, 07-01, Volume: 19, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiomyopathies; Cause of Death; Cohort Studies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Survival Analysis; Young Adult	2018
Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by Internal medicine (Tokyo, Japan), 2018, Jun-01, Volume: 57, Issue:11 Topics: Aortitis; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sarcoidosis	2018
Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circulation. Cardiovascular imaging, 2018, Volume: 11, Issue:1 Topics: Aged; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2018
Establishing an Evidence-Based Method to Diagnose Cardiac Sarcoidosis: The Complementary Use of Cardiac Magnetic Resonance Imaging and FDG-PET. Circulation. Cardiovascular imaging, 2018, Volume: 11, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis	2018
A case of longitudinal care of a patient with cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:2 Topics: Adult; Biopsy; Cardiomyopathies; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Practice Guidelines as Topic; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon	2018
Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:5 Topics: Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Gadolinium; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon	2019
11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRI. Clinical nuclear medicine, 2018, Volume: 43, Issue:6 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Thionucleosides; Thymidine	2018
Left atrial sarcoidosis as a substrate for peri-mitral atrial flutter: an unusual, underlying atrial disease. European heart journal, 2018, 08-14, Volume: 39, Issue:31 Topics: Atrial Flutter; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis	2018
Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis. International heart journal, 2018, May-30, Volume: 59, Issue:3 Topics: Aged; Atrioventricular Block; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Sarcoidosis	2018
18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:1 Topics: Adult; Aged; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis	2020
Non-diagnostic Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:5 Topics: Aged; Cardiomyopathies; Diabetes Mellitus, Type 2; Fatty Acids; Fluorodeoxyglucose F18; Heart; Humans; Insulin; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Patient Compliance; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon	2019
Importance of extracardiac FDG uptake to diagnose cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron-Emission Tomography; Sarcoidosis	2020
The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Risk; Sarcoidosis; Tomography, X-Ray Computed	2020
Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis. Clinical radiology, 2019, Volume: 74, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Sarcoidosis; Young Adult	2019
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6 Topics: Aged; Biopsy; Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Fluoroscopy; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2020
Prognostic Impact of FDG-PET/CT Images in Patients With Suspected Cardiac Sarcoidosis: Optimal Patient Preparation, Not Complex Unconventional Analytics, Is Key to Meaningful Data. JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Sarcoidosis	2019
Cardiac FDG/PET imaging mimicking sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:3 Topics: Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Thrombosis	2019
Occasionally increased Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:6 Topics: Atrial Fibrillation; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Electrocardiography; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Ventricles; Humans; Liposarcoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2 Topics: Cardiomyopathies; Female; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Heart; Humans; Imaging, Three-Dimensional; Inflammation; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis	2020
FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:1 Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2021
Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:1 Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume	2021
Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis. Journal of cardiac failure, 2019, Volume: 25, Issue:4 Topics: Cardiomyopathies; Drug Therapy, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors	2019
Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:7 Pt 1 Topics: Aged; Cardiomyopathies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis	2019
Left atrial involvement of cardiac sarcoidosis manifesting as left atrial re-entrant tachycardia. European heart journal. Cardiovascular Imaging, 2019, Aug-01, Volume: 20, Issue:8 Topics: Cardiomyopathies; Contrast Media; Diagnosis, Differential; Echocardiography, Transesophageal; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Magnetic Resonance Imaging, Cine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tachycardia, Supraventricular	2019
Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circulation. Cardiovascular imaging, 2019, Volume: 12, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity	2019
Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography. ESC heart failure, 2019, Volume: 6, Issue:4 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2019
No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:11 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Motion; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Ventricular Dysfunction, Left	2019
Cardiac sarcoid or arrhythmogenic right ventricular cardiomyopathy: a role for positron emission tomography (PET)? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:3 Topics: Arrhythmogenic Right Ventricular Dysplasia; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis	2013
Predictors of cardiac sarcoidosis using commonly available cardiac studies. The American journal of cardiology, 2013, Jul-15, Volume: 112, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cardiac Imaging Techniques; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2013
Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:10 Topics: Aged; Atrioventricular Block; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Septum	2013
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. The international journal of cardiovascular imaging, 2013, Volume: 29, Issue:7 Topics: Cardiomyopathies; Coronary Artery Bypass; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Stunning; Myocardium; Patient Selection; Percutaneous Coronary Intervention; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2013
Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography? Circulation. Cardiovascular imaging, 2013, Volume: 6, Issue:5 Topics: Adult; Aged; Area Under Curve; Atrioventricular Block; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Registries; ROC Curve; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Tomography, X-Ray Computed; Ventricular Function, Left	2013
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. Journal of the American College of Cardiology, 2014, Feb-04, Volume: 63, Issue:4 Topics: Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rubidium Radioisotopes; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular	2014
Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014, Volume: 21, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Myocardium; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes; Sarcoidosis; Treatment Outcome; Ventricular Function, Left	2014
Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Annals of nuclear medicine, 2014, Volume: 28, Issue:4 Topics: Cardiomyopathies; Diet; Fasting; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Time Factors; Whole Body Imaging	2014
Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. Journal of cardiovascular electrophysiology, 2014, Volume: 25, Issue:8 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Atrioventricular Block; Biopsy; Cardiomyopathies; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Male; Middle Aged; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sarcoidosis; Tachycardia, Ventricular; Time Factors; Tomography, X-Ray Computed; Young Adult	2014
Effect of time-of-flight and point spread function modeling on detectability of myocardial defects in PET. Medical physics, 2014, Volume: 41, Issue:6 Topics: Cardiomyopathies; Computer Simulation; Fluorodeoxyglucose F18; Heart; Humans; Image Interpretation, Computer-Assisted; Models, Theoretical; Poisson Distribution; Positron-Emission Tomography	2014
Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol. Annals of the Academy of Medicine, Singapore, 2014, Volume: 43, Issue:7 Topics: Adult; Cardiac Imaging Techniques; Cardiomyopathies; Clinical Protocols; Diet, Carbohydrate-Restricted; Diet, High-Fat; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2014
Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:18 Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed	2014
FDG-PET in a myocardial tuberculoma. Age and ageing, 2015, Volume: 44, Issue:1 Topics: Aged, 80 and over; Antitubercular Agents; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Treatment Outcome; Tuberculoma; Tuberculosis, Cardiovascular	2015
Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography. Journal of cardiac failure, 2015, Volume: 21, Issue:4 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed	2015
[Active cardiac sarcoidosis: Diagnosis and adjustment of therapy with FDG PET/CT]. Presse medicale (Paris, France : 1983), 2015, Volume: 44, Issue:6 Pt 1 Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2015
Late gadolinium enhancement on CMR and sustained ventricular tachycardia predict severe cardiac inflammation. Acta cardiologica, 2014, Volume: 69, Issue:6 Topics: Adult; Biopsy; Cardiomyopathies; Contrast Media; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon	2014
Pleomorphism during Ventricular Tachycardia: A Distinguishing Feature between Cardiac Sarcoidosis and Idiopathic VT. Pacing and clinical electrophysiology : PACE, 2015, Volume: 38, Issue:6 Topics: Adult; Cardiomyopathies; Contrast Media; Diagnosis, Differential; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed	2015
False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:6 Topics: Ammonia; Cardiomyopathies; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Peritoneal Dialysis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2015
Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis. International journal of cardiology, 2015, Sep-15, Volume: 195 Topics: Aged; Cardiomyopathies; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block. Heart rhythm, 2015, Volume: 12, Issue:12 Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Heart Block; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome	2015
Cardiac sarcoidosis with visually normal wall motion: role of cardiac MRI, FDG PET, and strain echocardiography. European heart journal. Cardiovascular Imaging, 2015, Volume: 16, Issue:11 Topics: Cardiomyopathies; Echocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2015
The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarco Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:2 Topics: Adult; Aged; Cardiomyopathies; Diet, Carbohydrate-Restricted; Fasting; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Heparin; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis	2016
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart rhythm, 2015, Volume: 12, Issue:12 Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Referral and Consultation; Tomography, X-Ray Computed	2015
Undiagnosed cardiac sarcoidosis presenting as complete heart block and ventricular arrhythmia. BMJ case reports, 2015, Aug-17, Volume: 2015 Topics: Cardiomyopathies; Defibrillators, Implantable; Fluorodeoxyglucose F18; Heart Block; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Tachycardia, Ventricular	2015
Cardiac positron emission tomography imaging with quantification of fluorodeoxyglucose for the detection of cardiac sarcoidosis. International journal of cardiology, 2015, Dec-15, Volume: 201 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardium; Sarcoidosis	2015
Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Conduction System; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed	2016
F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis. The American journal of cardiology, 2015, Nov-15, Volume: 116, Issue:10 Topics: Cardiomyopathies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis	2015
Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis. Osaka city medical journal, 2015, Volume: 61, Issue:1 Topics: Adult; Aged; Biopsy; Cardiomyopathies; Contrast Media; Early Diagnosis; Fatty Acids; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Iodobenzenes; Japan; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon	2015
Two cases of cardiac sarcoidosis diagnosed based on biopsy results of the gluteus muscle with focal uptake of 18F-fluorodeoxyglucose. European heart journal, 2016, Apr-07, Volume: 37, Issue:14 Topics: Biopsy; Buttocks; Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis	2016
Left ventricular asynchrony in early isolated cardiac sarcoidosis. European heart journal. Cardiovascular Imaging, 2016, Volume: 17, Issue:1 Topics: Adult; Cardiomyopathies; Coronary Angiography; Early Diagnosis; Fluorodeoxyglucose F18; Gadolinium; Glucocorticoids; Humans; Magnetic Resonance Imaging, Cine; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ventricular Dysfunction, Left	2016
Simultaneous cardiac imaging to detect inflammation and scar tissue with (18)F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:5 Topics: Cardiomyopathies; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2016
Right ventricular mass: a rare presentation of cardiac sarcoidosis. European heart journal, 2016, Mar-14, Volume: 37, Issue:11 Topics: Adult; Cardiomyopathies; Echocardiography; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2016
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells. Anticancer research, 2016, Volume: 36, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Carvedilol; Cell Line, Tumor; Cell Survival; Dexrazoxane; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Enalapril; Female; Fluorodeoxyglucose F18; Humans; Metformin; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab	2016
Diagnosis, therapeutic response assessment, and detection of disease recurrence in cardiac sarcoidosis: Integral role of cardiac PET. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis	2016
FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab. Clinical nuclear medicine, 2016, Volume: 41, Issue:5 Topics: Adalimumab; Anti-Inflammatory Agents; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome	2016
Continuing evolution in preparation protocols for Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:3 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals	2017
Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis. European heart journal, 2016, 09-01, Volume: 37, Issue:33 Topics: Adult; Cardiac Resynchronization Therapy; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Heart Failure; Humans; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome	2016
Cardiac manifestations of sarcoidosis: diagnosis and management. European heart journal, 2017, Sep-14, Volume: 38, Issue:35 Topics: Adolescent; Adult; Aged; Biomarkers; Biopsy; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Early Diagnosis; Echocardiography; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Young Adult	2017
Cardiac sarcoidosis: An important niche for PET, but a journey just begun. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2017
Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:4 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2018
Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction. BMJ case reports, 2016, Oct-25, Volume: 2016 Topics: Aged; Biopsy; Cardiomyopathies; Contrast Media; Defibrillators, Implantable; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Torsades de Pointes; Ventricular Fibrillation	2016
The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1 Topics: Cardiomyopathies; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome	2017
Multimodality imaging in the diagnosis and management of cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis	2017
Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. International journal of cardiology, 2017, Feb-01, Volume: 228 Topics: Adrenal Cortex Hormones; Adult; Cardiomyopathies; Cohort Studies; Drug Resistance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome	2017
Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis. Clinical nuclear medicine, 2017, Volume: 42, Issue:2 Topics: Adult; Aged; Cardiomyopathies; Diet, Carbohydrate-Restricted; Diet, High-Fat; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis	2017
Diagnosis of myocardial abscess secondary to infective endocarditis by Medicina clinica, 2017, Feb-23, Volume: 148, Issue:4 Topics: Abscess; Cardiomyopathies; Endocarditis, Bacterial; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Staphylococcal Infections	2017
Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis. JACC. Cardiovascular imaging, 2017, Volume: 10, Issue:2 Topics: Ammonia; Blood Flow Velocity; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Humans; Hyperemia; Immunosuppressive Agents; Male; Middle Aged; Myocardial Perfusion Imaging; Myocarditis; Nitrogen Radioisotopes; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors; Treatment Outcome; Vasodilation	2017
Quantitative Assessment of Myocardial Blood Flow in Cardiac Sarcoidosis: A Potential Next Step in the Further Integration of FDG-PET in Imaging Management? JACC. Cardiovascular imaging, 2017, Volume: 10, Issue:2 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2017
The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. Journal of cardiology, 2008, Volume: 51, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left	2008
Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:8 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Revascularization; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left	2008
Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment. Nuclear medicine communications, 2008, Volume: 29, Issue:11 Topics: Aged; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Rubidium Radioisotopes; Ventricular Dysfunction, Left	2008
Effects of left bundle branch block and right ventricular pacing on assessing myocardial viability by positron emission tomography. JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5 Topics: Aged, 80 and over; Bundle-Branch Block; Cardiac Pacing, Artificial; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival	2009
Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2010, Volume: 17, Issue:2 Topics: Arrhythmias, Cardiac; Cardiomyopathies; Coronary Angiography; Coronary Artery Disease; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Syncope; Tachycardia, Ventricular; Ventricular Dysfunction, Left	2010
Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy. Heart rhythm, 2009, Volume: 6, Issue:12 Topics: Aged; Bundle-Branch Block; Cardiac Resynchronization Therapy; Cardiomyopathies; Confidence Intervals; Female; Fibrosis; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio; Positron-Emission Tomography; Prospective Studies; ROC Curve; Rubidium; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling	2009
An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2010, Volume: 17, Issue:4 Topics: Aged; Cardiomyopathies; Diabetes Complications; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2010
Clinical problem-solving. The beat goes on. The New England journal of medicine, 2010, May-06, Volume: 362, Issue:18 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Myocardium; Prednisone; Sarcoidosis; Tachycardia, Ventricular; Ventricular Dysfunction, Right	2010
Cardiac sarcoidosis mimicking non-ST-elevation myocardial infarction. Journal of cardiovascular medicine (Hagerstown, Md.), 2012, Volume: 13, Issue:4 Topics: Adult; Cardiomyopathies; Diagnosis, Differential; Electrophysiologic Techniques, Cardiac; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Myocardial Infarction; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome	2012
Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle. Cardiovascular diabetology, 2010, Jun-15, Volume: 9 Topics: Animals; Blood Glucose; Cardiomyopathies; Diabetes Mellitus, Type 2; Disease Models, Animal; Dyslipidemias; Echocardiography, Doppler; Fatty Acids; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart Ventricles; Hyperinsulinism; Insulin; Male; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiopharmaceuticals; Rats; Rats, Zucker; Triglycerides; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right	2010
Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC. Cardiovascular imaging, 2010, Volume: 3, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Cardiomyopathy, Dilated; Fasting; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Time Factors; Treatment Outcome; Ultrasonography	2010
Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2011, Volume: 18, Issue:2 Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon	2011
Diagnosing isolated cardiac sarcoidosis. Journal of internal medicine, 2011, Volume: 270, Issue:5 Topics: Adult; Biopsy; Cardiomyopathies; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed	2011
Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:11 Topics: Aged; Cardiomyopathies; Early Diagnosis; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoidosis	2011
Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2011, Volume: 28, Issue:1 Topics: Cardiomyopathies; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index	2011
Diagnosis of cardiac sarcoidosis through mismatched defects seen on N-13 NH3/F-18 FDG cardiac PET. Clinical nuclear medicine, 2011, Volume: 36, Issue:12 Topics: Ammonia; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Radiography; Sarcoidosis	2011
Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2012, Volume: 19, Issue:1 Topics: Aged; Cardiac Resynchronization Therapy; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Septum; Humans; Male; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome	2012
Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegaly. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:1 Topics: Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Splenomegaly	2012
Multimodality evaluation of cardiac sarcoidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2012, Volume: 19, Issue:3 Topics: Adult; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed	2012
Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. International heart journal, 2012, Volume: 53, Issue:5 Topics: Aged; Biomarkers; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Muramidase; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Stroke Volume; Troponin T; Ventricular Function, Left	2012
Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:4 Topics: Adult; Aged; Blood Glucose; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Nitrogen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow	2013
Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity. Clinical nuclear medicine, 2013, Volume: 38, Issue:2 Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heparin; Humans; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed	2013
Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:7 Topics: Adult; Aged; Ammonia; Carbon Isotopes; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed	2003
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy. The American journal of cardiology, 2003, Sep-15, Volume: 92, Issue:6 Topics: Aged; Cardiomyopathies; Coronary Artery Disease; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left	2003
Patterns of papillary muscle ischemia in myocardial PET. Clinical nuclear medicine, 2004, Volume: 29, Issue:1 Topics: Ammonia; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Muscular Diseases; Nitrogen Radioisotopes; Papillary Muscles; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Usefulness of 18FDG/13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:8 Topics: Ammonia; Cardiomyopathies; Churg-Strauss Syndrome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Prednisolone; Prognosis; Treatment Outcome	2004
Failure of follow-up gallium single-photon emission computed tomography and fluorine-18-fluorodeoxyglucose positron emission tomography to predict the deterioration of a patient with cardiac sarcoidosis. Circulation journal : official journal of the Japanese Circulation Society, 2004, Volume: 68, Issue:8 Topics: Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Treatment Failure; Ventricular Function, Left	2004
Diagnostic Value of PET in Cardiac Sarcoidosis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:11 Topics: Adult; Aged; Cardiomyopathies; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Thallium; Tissue Distribution; Tomography, Emission-Computed	2004
Assessment of myocardial viability by nuclear imaging techniques. Current cardiology reports, 2005, Volume: 7, Issue:2 Topics: Animals; Cardiomyopathies; Diabetes Complications; Disease Models, Animal; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Stroke Volume; Swine; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left	2005
Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. European heart journal, 2005, Volume: 26, Issue:15 Topics: Adult; Aged; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Sestamibi	2005
Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction. Coronary artery disease, 2005, Volume: 16, Issue:3 Topics: Cardiomyopathies; Coronary Artery Bypass; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Netherlands; Prognosis; Prospective Studies; Radiopharmaceuticals; Stroke Volume; Survival Analysis; Systole; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler, Pulsed; Ventricular Dysfunction, Left	2005
[Fluorodeoxyglucose-positron emission tomographic findings in a patient with pacing failure]. Journal of cardiology, 2005, Volume: 45, Issue:4 Topics: Aged; Cardiomyopathies; Equipment Failure; Female; Fluorodeoxyglucose F18; Heart Block; Humans; Pacemaker, Artificial; Sarcoidosis; Tomography, Emission-Computed	2005
[Cardiac sarcoidosis detected by FDG-PET]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Jul-10, Volume: 94, Issue:7 Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2005
[A case of high FDG-uptake into the myocardium after radiotherapy for esophageal cancer]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2005, Volume: 65, Issue:3 Topics: Aged; Carcinoma, Squamous Cell; Cardiomyopathies; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Myocardium; Positron-Emission Tomography; Radiation Injuries	2005
Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2005, Volume: 22, Issue:3 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis	2005
Relation of end-diastolic wall thickness and the residual rim of viable myocardium by magnetic resonance imaging to myocardial viability assessed by fluorine-18 deoxyglucose positron emission tomography. The American journal of cardiology, 2006, Feb-15, Volume: 97, Issue:4 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tissue Survival	2006
Evaluation of myocardial glucose metabolism before and after recovery of myocardial function in patients with tachycardia-induced cardiomyopathy. Pacing and clinical electrophysiology : PACE, 2006, Volume: 29, Issue:2 Topics: Cardiomyopathies; Case-Control Studies; Catheter Ablation; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function; Tachycardia; Ventricular Dysfunction, Left	2006
Images in cardiology. Cardiac sarcoidosis in a 60 year old woman. Heart (British Cardiac Society), 2006, Volume: 92, Issue:5 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2006
[A case of takotsubo cardiomyopathy provoked by taking a new quinolone antibiotic drug and a non-steroidal anti-inflammatory drug]. Kaku igaku. The Japanese journal of nuclear medicine, 2006, Volume: 43, Issue:1 Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiomyopathies; Electrocardiography; Fatty Acids; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Levofloxacin; Ofloxacin; Phenylpropionates; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA-A; Tomography, Emission-Computed, Single-Photon	2006
Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation, 2006, May-23, Volume: 113, Issue:20 Topics: Adult; Cardiomyopathies; Chest Pain; Female; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Steroids; Tissue Distribution; Treatment Outcome	2006
Takotsubo cardiomyopathy in positron emission tomography. Wiener klinische Wochenschrift, 2006, Volume: 118, Issue:17-18 Topics: Aged; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Myocardial Stunning; Positron-Emission Tomography; Time Factors; Ventricular Dysfunction, Left	2006
FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:3 Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Ischemia; Patient Selection; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome	2007
Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. The European respiratory journal, 2007, Volume: 29, Issue:2 Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoidosis	2007
18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker. Thorax, 2007, Volume: 62, Issue:6 Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart Block; Humans; Male; Middle Aged; Pacemaker, Artificial; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Syncope	2007
A failed case to diagnose cardiac sarcoidosis presenting advanced atrioventricular block. International journal of cardiology, 2008, Sep-26, Volume: 129, Issue:2 Topics: Anti-Inflammatory Agents; Atrioventricular Block; Cardiomyopathies; Diagnostic Errors; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Organ Failure; Prednisolone; Sarcoidosis; Uveitis	2008
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:5 Topics: Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique	2008
Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2007, Volume: 24, Issue:2 Topics: Adult; Aged; Carbon Radioisotopes; Cardiomyopathies; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis	2007
[Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis]. Journal of cardiology, 2000, Volume: 35, Issue:4 Topics: Animals; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Sarcoidosis; Tomography, Emission-Computed; Treatment Outcome	2000
The clinical use of PET--where are we now? The British journal of radiology, 2001, Volume: 74, Issue:881 Topics: Cardiomyopathies; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Half-Life; Humans; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2001
99mTc-Sestamibi SPECT is a useful technique for viability detection: results of a comparison with NH3/FDG PET. Scandinavian cardiovascular journal : SCJ, 2001, Volume: 35, Issue:4 Topics: Adult; Aged; Ammonia; Cardiomyopathies; Cell Survival; Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Nitrogen Radioisotopes; Random Allocation; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon	2001
Detection of myocardial involvement in systemic lupus erythematosus: mismatch between normal perfusion scans with 201Thallium and pathological 18FDG uptake. International angiology : a journal of the International Union of Angiology, 2001, Volume: 20, Issue:4 Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Reference Values; Thallium Radioisotopes; Tomography, Emission-Computed	2001
Assessment of viable tissue in Q-wave regions by metabolic imaging using single-photon emission computed tomography in ischemic cardiomyopathy. The American journal of cardiology, 2002, May-15, Volume: 89, Issue:10 Topics: Aged; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Image Enhancement; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left	2002